These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5787500)

  • 21. Renal drug metabolism.
    Lohr JW; Willsky GR; Acara MA
    Pharmacol Rev; 1998 Mar; 50(1):107-41. PubMed ID: 9549760
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transformation and excretion potentials of drugs].
    Stormann H
    Wien Klin Wochenschr; 1967 Feb; 79(5):81-7. PubMed ID: 5591361
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 24. Refresher courses in pharmacology. 4. The biotransformation of drugs.
    Jenkins WL
    J S Afr Vet Med Assoc; 1971 Sep; 42(3):211-6. PubMed ID: 5161402
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatic enzyme induction and drug effects].
    Paumgartner G
    Ther Umsch; 1971 Apr; 28(4):234-40. PubMed ID: 5575081
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preclinical investigation and testing of nontoxicity of drugs in the pharmaceutrial industry].
    Tripod J
    Schweiz Med Wochenschr; 1968 Aug; 98(31):1152-8. PubMed ID: 4236567
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mechanisms of pharmacokinetic drug interactions. 4: Mechanisms of interaction during biotransformation].
    Box A; Heydel E; Fürtig W
    Pharmazie; 1984 Apr; 39(4):282-92. PubMed ID: 6377334
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biotransformation of drugs by the liver].
    González Macias JG
    Rev Clin Esp; 1974 Nov; 135(3):207-18. PubMed ID: 4615350
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council.
    Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative patterns of drug metabolism.
    Williams RT
    Fed Proc; 1967; 26(4):1029-39. PubMed ID: 6028768
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of tobacco smoking on drug metabolism].
    Stańkowska-Chomicz A
    Pol Tyg Lek; 1982 Jul; 37(23):689-91. PubMed ID: 7177964
    [No Abstract]   [Full Text] [Related]  

  • 32. Is glucuronidation truly preserved in patients with liver disease?
    Hoyumpa AM; Schenker S
    Hepatology; 1991 Apr; 13(4):786-95. PubMed ID: 1901292
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biotransformation of drugs. 1. Problems and general metabolic routes].
    Pfeifer S
    Pharmazie; 1968 May; 23(5):225-36. PubMed ID: 5717164
    [No Abstract]   [Full Text] [Related]  

  • 34. Preparation of N-dealkylated drug metabolites by electrochemical simulation of biotransformation.
    Shono T; Toda T; Oshino N
    Drug Metab Dispos; 1981; 9(5):481-2. PubMed ID: 6117450
    [No Abstract]   [Full Text] [Related]  

  • 35. Peroxidases: a role in the metabolism and side effects of drugs.
    Tafazoli S; O'Brien PJ
    Drug Discov Today; 2005 May; 10(9):617-25. PubMed ID: 15894226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bio-reduction in the activation of drugs. Proceedings of the Second Biochemical Pharmacology Symposium. Oxford, 25-26 July 1985.
    Biochem Pharmacol; 1986 Jan; 35(1):1-122. PubMed ID: 3940520
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the biotransformation of drugs and its significance in pharmaceutical industry].
    Hansen T
    Nord Med; 1967 Nov; 78(47):1549-54. PubMed ID: 6075279
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug metabolism of the lung].
    Yue TL
    Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):128-36. PubMed ID: 7433961
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolically oxygenated compounds: formation, conjugation, and possible biological implications.
    Schreiber EC
    J Pharm Sci; 1974 Aug; 63(8):1177-90. PubMed ID: 4604759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.